BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

125 related articles for article (PubMed ID: 9705747)

  • 1. Immunochemical identification of hepatic protein adducts derived from estragole.
    Wakazono H; Gardner I; Eliasson E; Coughtrie MW; Kenna JG; Caldwell J
    Chem Res Toxicol; 1998 Aug; 11(8):863-72. PubMed ID: 9705747
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Immunochemical detection of covalently modified protein adducts in livers of rats treated with methyleugenol.
    Gardner I; Bergin P; Stening P; Kenna JG; Caldwell J
    Chem Res Toxicol; 1996 Jun; 9(4):713-21. PubMed ID: 8831815
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Selective protein adducts to membrane proteins in cultured rat hepatocytes exposed to diclofenac: radiochemical and immunochemical analysis.
    Kretz-Rommel A; Boelsterli UA
    Mol Pharmacol; 1994 Feb; 45(2):237-44. PubMed ID: 8114673
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Immunochemical identification of mouse hepatic protein adducts derived from the nonsteroidal anti-inflammatory drugs diclofenac, sulindac, and ibuprofen.
    Wade LT; Kenna JG; Caldwell J
    Chem Res Toxicol; 1997 May; 10(5):546-55. PubMed ID: 9168252
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A physiologically based biodynamic (PBBD) model for estragole DNA binding in rat liver based on in vitro kinetic data and estragole DNA adduct formation in primary hepatocytes.
    Paini A; Punt A; Viton F; Scholz G; Delatour T; Marin-Kuan M; Schilter B; van Bladeren PJ; Rietjens IM
    Toxicol Appl Pharmacol; 2010 May; 245(1):57-66. PubMed ID: 20144636
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Chemical and immunochemical comparison of protein adduct formation of four carboxylate drugs in rat liver and plasma.
    Bailey MJ; Dickinson RG
    Chem Res Toxicol; 1996; 9(3):659-66. PubMed ID: 8728513
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Major role of hepatic sulfotransferase activity in the metabolic activation, DNA adduct formation, and carcinogenicity of 1'-hydroxy-2',3'-dehydroestragole in infant male C57BL/6J x C3H/HeJ F1 mice.
    Fennell TR; Wiseman RW; Miller JA; Miller EC
    Cancer Res; 1985 Nov; 45(11 Pt 1):5310-20. PubMed ID: 3863702
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Halothane metabolism: immunochemical evidence for molecular mimicry of trifluoroacetylated liver protein adducts by constitutive polypeptides.
    Christen U; Bürgin M; Gut J
    Mol Pharmacol; 1991 Sep; 40(3):390-400. PubMed ID: 1716732
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Identification of nevadensin as an important herb-based constituent inhibiting estragole bioactivation and physiology-based biokinetic modeling of its possible in vivo effect.
    Alhusainy W; Paini A; Punt A; Louisse J; Spenkelink A; Vervoort J; Delatour T; Scholz G; Schilter B; Adams T; van Bladeren PJ; Rietjens IM
    Toxicol Appl Pharmacol; 2010 Jun; 245(2):179-90. PubMed ID: 20226806
    [TBL] [Abstract][Full Text] [Related]  

  • 10. In vivo validation of DNA adduct formation by estragole in rats predicted by physiologically based biodynamic modelling.
    Paini A; Punt A; Scholz G; Gremaud E; Spenkelink B; Alink G; Schilter B; van Bladeren PJ; Rietjens IM
    Mutagenesis; 2012 Nov; 27(6):653-63. PubMed ID: 22844077
    [TBL] [Abstract][Full Text] [Related]  

  • 11. NTP technical report on the toxicity and metabolism studies of chloral hydrate (CAS No. 302-17-0). Administered by gavage to F344/N rats and B6C3F1 mice.
    Beland FA
    Toxic Rep Ser; 1999 Aug; (59):1-66, A1-E7. PubMed ID: 11803702
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Human cytochrome p450 enzyme specificity for the bioactivation of estragole and related alkenylbenzenes.
    Jeurissen SM; Punt A; Boersma MG; Bogaards JJ; Fiamegos YC; Schilter B; van Bladeren PJ; Cnubben NH; Rietjens IM
    Chem Res Toxicol; 2007 May; 20(5):798-806. PubMed ID: 17407329
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Sex differences in the activation of tamoxifen to DNA binding species in rat liver in vivo and in rat hepatocytes in vitro: role of sulfotransferase induction.
    Davis W; Hewer A; Rajkowski KM; Meinl W; Glatt H; Phillips DH
    Cancer Res; 2000 Jun; 60(11):2887-91. PubMed ID: 10850433
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A physiologically based biokinetic (PBBK) model for estragole bioactivation and detoxification in rat.
    Punt A; Freidig AP; Delatour T; Scholz G; Boersma MG; Schilter B; van Bladeren PJ; Rietjens IM
    Toxicol Appl Pharmacol; 2008 Sep; 231(2):248-59. PubMed ID: 18539307
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Possible involvement of genotoxic mechanisms in estragole-induced hepatocarcinogenesis in rats.
    Suzuki Y; Umemura T; Hibi D; Inoue T; Jin M; Ishii Y; Sakai H; Nohmi T; Yanai T; Nishikawa A; Ogawa K
    Arch Toxicol; 2012 Oct; 86(10):1593-601. PubMed ID: 22576464
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Covalent binding of sulfamethoxazole reactive metabolites to human and rat liver subcellular fractions assessed by immunochemical detection.
    Cribb AE; Nuss CE; Alberts DW; Lamphere DB; Grant DM; Grossman SJ; Spielberg SP
    Chem Res Toxicol; 1996 Mar; 9(2):500-7. PubMed ID: 8839055
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cellular levels and molecular dynamics simulations of estragole DNA adducts point at inefficient repair resulting from limited distortion of the double-stranded DNA helix.
    Yang S; Diem M; Liu JDH; Wesseling S; Vervoort J; Oostenbrink C; Rietjens IMCM
    Arch Toxicol; 2020 Apr; 94(4):1349-1365. PubMed ID: 32185416
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Metabolism of allylbenzene 2',3'-oxide and estragole 2',3'-oxide in the isolated perfused rat liver.
    Luo G; Guenthner TM
    J Pharmacol Exp Ther; 1995 Feb; 272(2):588-96. PubMed ID: 7853172
    [TBL] [Abstract][Full Text] [Related]  

  • 19. In vivo validation and physiologically based biokinetic modeling of the inhibition of SULT-mediated estragole DNA adduct formation in the liver of male Sprague-Dawley rats by the basil flavonoid nevadensin.
    Alhusainy W; Paini A; van den Berg JH; Punt A; Scholz G; Schilter B; van Bladeren PJ; Taylor S; Adams TB; Rietjens IM
    Mol Nutr Food Res; 2013 Nov; 57(11):1969-78. PubMed ID: 23894034
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Immunochemical detection of flucloxacillin adduct formation in livers of treated rats.
    Carey MA; van Pelt FN
    Toxicology; 2005 Dec; 216(1):41-8. PubMed ID: 16112790
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.